Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

Vietnam suspends new food safety regulations

10/04/2026 Published by vivi

The Government has issued Resolution 15, officially suspending the implementation of Decree 46 and Resolution 66.13 regarding food safety management.... Read more

Tags: #Vietnam

GC Biopharma validates proprietary technology to mitigate thromboembolic risks

08/04/2026 Published by vivi

GC Biopharma has successfully developed and validated a proprietary assay designed to precisely measure impurities linked to thromboembolic risks. This... Read more

Category: Uncategorized

Tags: #Global Trends

Vertex Pharmaceuticals and Halozyme enter exclusive drug delivery partnership

08/04/2026 Published by vivi

Halozyme Therapeutics Inc. has finalized a global exclusive collaboration and licensing agreement with Vertex Pharmaceuticals Incorporated. Under this pact, Vertex... Read more

Category: Uncategorized

Tags: #Global Trends

AC Immune and Eli Lilly amend partnership to develop Alzheimer’s therapies

08/04/2026 Published by vivi

AC Immune SA and Eli Lilly and Company have officially amended their 2018 licensing and collaboration agreement to advance the... Read more

Category: Uncategorized

Tags: #Global Trends

Biocon launches two Denosumab biosimilars, Aukelso and Bosaya, in the U.S. market

08/04/2026 Published by vivi

Pharmaceutical giant Biocon has officially commenced the commercial launch of two biosimilars, Aukelso and Bosaya, in the United States. These... Read more

Category: Uncategorized

Tags: #Global Trends

Amgen reports success in Phase 3 trial of subcutaneous Tepezza

08/04/2026 Published by vivi

Amgen has announced that a subcutaneous version of its blockbuster drug Tepezza—a treatment for thyroid eye disease (TED)—successfully met both... Read more

Category: Uncategorized

Tags: #Global Trends

Sanofi reports mixed mid-stage clinical results for its new immunotherapy hopeful

08/04/2026 Published by vivi

Sanofi has announced Phase 2 trial results for Lunsekimig, a bispecific biologic targeting two well-known drivers of inflammation: TSLP and... Read more

Category: Uncategorized

Tags: #Global Trends

Gilead Sciences acquires biotech firm Tubulis in a deal worth up to $5 billion

08/04/2026 Published by vivi

Gilead Sciences has announced an agreement to acquire Tubulis, a German biotechnology startup, in a transaction valued at potentially $5... Read more

Category: Uncategorized

Tags: #M&A

Neurocrine Biosciences executes historic $2.9B acquisition of Soleno Therapeutics

08/04/2026 Published by vivi

Defying its long-standing reputation as a potential takeover target, Neurocrine Biosciences has taken a decisive step by acquiring Soleno Therapeutics... Read more

Category: Uncategorized

Tags: #M&A

Posts pagination

Previous page Page 1 … Page 127 Page 128 Page 129 … Page 228 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members